KOLESIE are the call here and the H2H record is where we start. Four wins from five meetings against GenOne is not a coincidence at this level, it is a matchup problem for GenOne that the current market is not pricing adequately. KOLESIE bring a 75% Nuke win rate across 16 maps as their clearest strength. GenOne have played zero Mirage maps in this data set, which means KOLESIE can anchor the veto around their Nuke comfort and force GenOne onto ground they have not prepared for competitively. KOLESIE's Anubis at 50% (10 maps) is also more battle-tested than GenOne's 64% across just 11 maps. The public lean toward GenOne here is driven by a slightly higher HLTV ranking (54 vs 62) and their recent run of W-L-W-L-W across the last five matches. But KOLESIE's trajectory looks better on closer inspection: their last five reads L-W-W-W-W, including wins over Bebop, HEROIC Academy, SPARTA and Virtus.pro. GenOne's wins came against SPARTA and Lazer Cats, softer opposition. At this tier the schedule context matters more than the raw record. The market here is thin so we size this modestly, but the map pool edge and the commanding H2H give us enough independent conviction to include KOLESIE as the third pick on today's card.